Saudi Arabia Genome Editing Market Size & Outlook
Saudi Arabia genome editing market, 2018-2030 (US$M)
Related Markets
Saudi Arabia genome editing market highlights
- The Saudi Arabia genome editing market generated a revenue of USD 95.1 million in 2023 and is expected to reach USD 219.9 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 12.7% from 2024 to 2030.
- In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2023.
- (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
Genome editing market data book summary
| Market revenue in 2023 | USD 95.1 million |
| Market revenue in 2030 | USD 219.9 million |
| Growth rate | 12.7% (CAGR from 2023 to 2030) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | (CRISPR)/Cas9 |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Merck KGaA, Cibus Inc Ordinary Shares - Class A, Recombinetics, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision BioSciences Inc, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origene Technologies, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 1.2% of the global genome editing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia genome editing market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 166.6 million by 2030.
(crispr)/cas9 was the largest segment with a revenue share of 45.11% in 2023. Horizon Databook has segmented the Saudi Arabia genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2018 to 2030.
Ongoing research projects related to CRISPR genome editing technology are expected to boost the market growth over the forecast period. For instance, in February 2018, a research team at King Abdullah University of Science and Technology developed a new delivery system for introducing gene editing technology into cells.
This system is expected to help efficiently and safely correct diseasecausing mutations in patients. Moreover, this system will help overcome the CRISPR genome editing technology’s double delivery problem.
Furthermore, the rising adoption of CRISPR genome editing technology for enhancing immune system in plants is expected to drive market growth in the coming years. For instance, researchers at the King Abdullah University of Science and Technology are working on adapting CRISPR-Cas9 technology to function as an immunity system against plant DNA viruses.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Market Scope
Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia genome editing market size, by technology, 2018-2030 (US$M)
Saudi Arabia Genome Editing Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
